pharma news, views and analysis - pharmaphorum.com

Trending

in News
UCB posts more supportive data from Humira rival bimekizumab
December 6, 2019 Share
X
UCB posts more supportive data from Humira rival bimekizumab
https://pharmaphorum.com/news/ucb-posts-more-supportive-data-from-humira-rival-bimekizumab/
in News
Novartis pulls rival to Roche’s risdiplam in SMA, says market limited
December 6, 2019 Share
X
Novartis pulls rival to Roche’s risdiplam in SMA, says market limited
https://pharmaphorum.com/news/novartis-pulls-rival-to-roches-risdiplam-in-sma-says-market-limited/

Latest News

Novartis says mid-stage pipeline is setting up strong growth spurt

Novartis says mid-stage pipeline is setting up strong growth spurt

Novartis kicked off its R&D update in London this morning by pledging to bring at least 10 drugs

X

Novartis says mid-stage pipeline is setting up strong growth spurt

https://pharmaphorum.com/news/novartis-says-mid-stage-pipeline-is-setting-up-strong-growth-spurt/

Neurocrine and Xenon agree $1.75bn epilepsy R&D tie-up

Neurocrine and Xenon agree $1.75bn epilepsy R&D tie-up

Two biotechs, Neurocrine Biosciences and Xenon, have announced a licence and collaboration agreement to develop first-in-class treatments for

X

Neurocrine and Xenon agree $1.75bn epilepsy R&D tie-up

https://pharmaphorum.com/news/neurocrine-and-xenon-agree-1-75bn-epilepsy-rd-tie-up/

Astellas buys gene therapy company for $3bn

Astellas buys gene therapy company for $3bn

Astellas has announced it will be acquiring gene therapy specialists Audentes Therapeutics for a total equity value of

X

Astellas buys gene therapy company for $3bn

https://pharmaphorum.com/news/astellas-acquires-gene-therapy-company-for-3bn/

Views & Analysis

Harnessing the digital transformation of the drug development pathway

Harnessing the digital transformation of the drug development pathway

We have the evidence base to support the digital transformation of clinical trials – what we need now

X

Harnessing the digital transformation of the drug development pathway

https://pharmaphorum.com/views-analysis-digital/harnessing-the-digital-transformation-of-the-drug-development-pathway/

Real-world or real evidence?

Real-world or real evidence?

There was a time when the distinction between data from clinical trials and data from any other source

X

Real-world or real evidence?

https://pharmaphorum.com/r-d/views-analysis-r-d/real-world-or-real-evidence/

ABPI’s blueprint to build a pharma powerhouse in uncertain political times

ABPI’s blueprint to build a pharma powerhouse in uncertain political times

The UK is in the grips of election fever, but whoever takes the reins on 13 December will

X

ABPI’s blueprint to build a pharma powerhouse in uncertain political times

https://pharmaphorum.com/r-d/views-analysis-r-d/abpis-blueprint-to-build-a-pharma-powerhouse-in-uncertain-pollical-times/

Debates & Insights

Navigating new frontiers: Ways to find space in the future RA market

Navigating new frontiers: Ways to find space in the future RA market

Overview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15

X

Navigating new frontiers: Ways to find space in the future RA market

https://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

X

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Partner Content

13th Annual Pharma Resource Planning and Portfolio Management

13th Annual Pharma Resource Planning and Portfolio Management

Prioritizing Projects with Tools, Data, and Governance

X

13th Annual Pharma Resource Planning and Portfolio Management

https://pharmaphorum.com/events/13th-annual-pharma-resource-planning-and-portfolio-management/

3rd Annual Dermatology Drug Development Summit

3rd Annual Dermatology Drug Development Summit

Industry meeting on advancing derm drug development

X

3rd Annual Dermatology Drug Development Summit

https://pharmaphorum.com/events/3rd-annual-dermatology-drug-development-summit/

Your Ultimate Guide To The Skin Microbiome

Your Ultimate Guide To The Skin Microbiome

Your Ultimate Guide To The Skin Microbiome

X

Your Ultimate Guide To The Skin Microbiome

https://pharmaphorum.com/events/your-ultimate-guide-to-the-skin-microbiome/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com